NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Valeritas V-Go shows reduction in A1c levels by 1.5 and total daily insulin dosage by 14% » MDPR1

Valeritas V-Go shows reduction in A1c levels by 1.5 and total daily insulin dosage by 14%

Image: Valeritas V-Goshows reduction in A1c levels by 1.5 and total daily insulin dosage by 14%. Photo: Courtesy of meepoohyaphoto/FreeDigitalPhotos.net.

NS Medical Devices is using cookies

Image: Valeritas V-Goshows reduction in A1c levels by 1.5 and total daily insulin dosage by 14%. Photo: Courtesy of meepoohyaphoto/FreeDigitalPhotos.net.

Related Article

Biggest players in the global wound care market

RECOMMENDED COMPANIES

MOST READ

Exo introduces new cardiac and lung AI applications on Exo Iris

Penumbra launches latest CAVT technology to rapidly remove blood clots

Front Line Medical gets CE Mark for COBRA-OS occlusion device

FDA clears Epitel’s REMI EEG monitoring system and REMI Vigilenz AI platform

GE HealthCare, Elekta expand collaboration to boost radiation therapy

Recommended Whitepaper